Abstract
Male Sprague-Dawley rats were repeatedly treated with amphetamine (AMP, 1 mg/kg, SC) at 3- day intervals for 15 days and tested for prepulse inhibition of acoustic startle after each treatment. This treatment regimen induced sensitisation in the animals as evidenced by a progressive increase in the disruptive effect of AMP on prepulse inhibition. Persistent changes in brain function was indicated, since an increase in disruptive effect was observed in sensitised animals also after a 22-day-long drug- and test-free period. The development of sensitisation was blocked by pretreatment with haloperidol (HPD, 0.1 mg/kg, SC), which suggests that sensitisation to the disruptive effect of AMP was dependent on dopamine (DA) D2 receptor activation. Furthermore, the development of sensitisation was blocked by adrenalectomy, which suggests that sensitisation was dependent also on circulating adrenal hormones. Increased DA-ergic activity has been implicated in the pathophysiology of schizophrenia and AMP-induced sensitisation to the neuronal functions that modulate prepulse inhibition may be an experimental model to investigate this hypothesis.
Citations
Jul 20, 2006·Psychopharmacology·Julia A ChesterRobert L Meisel
Dec 20, 2005·Journal of Neural Transmission·D Peleg-RaibsteinJ Feldon
Jun 13, 2013·Behavioural Brain Research·Auxiliadora Mena, Luis G De la Casa
Mar 23, 2005·Biological Psychiatry·Catherine C TennShitij Kapur
Jan 31, 2006·Brain Research·Scott A Heldt, Kerry J Ressler
Apr 25, 2000·Brain Research·J A EngelL Svensson
Nov 14, 2003·Schizophrenia Research·Catherine C TennShitij Kapur
May 28, 2014·Neuroscience Letters·Alanna GrantCecilia Flores
Jun 14, 2008·Neuroscience and Biobehavioral Reviews·Stephen M Siviy
May 3, 2005·Behavioural Brain Research·Mehret Yerdaw BanjawWerner J Schmidt
Jan 21, 2006·Journal of Neuroscience Methods·Becky KinkeadArnold J Mandell
Sep 20, 2005·Behavioural Brain Research·Rainer WolfHerbert Schwegler
May 24, 2011·Pharmacology, Biochemistry, and Behavior·Ming LiJing Chen
Oct 8, 1999·Journal of Psychopharmacology·M T Martin-Iverson
Nov 1, 2003·The Journal of Pharmacology and Experimental Therapeutics·Kerry E Culm, Ronald P Hammer